Purchases and Sales Made in Q1 2023 in Iovance Biotherapeutics, Inc. (IOVA)
This table provides information about the institutional ownership of Iovance Biotherapeutics, Inc. (IOVA) during Q1 2023. The information is specifically focused on institutions that hold shares of IOVANCE BIOTHERAPEUTICS, INC..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 15, 2023
Q1 2023
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-923K- 6.38% |
$5.1M - $7.59M
|
13.5M
$78.3M
|
|
|
May 15, 2023
Q1 2023
|
State Street Corp
Boston, MA |
SELL
|
- |
-982K- 6.68% |
$5.43M - $8.08M
|
13.7M
$79.4M
|
|
|
May 15, 2023
Q1 2023
|
Ameriprise Financial Inc
Minneapolis, MN |
SELL
|
- |
-1.17M- 89.09% |
$6.46M - $9.6M
|
143K
$827K
|
|
|
May 12, 2023
Q1 2023
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-1.33M- 41.41% |
$7.33M - $10.9M
|
1.88M
$10.8M
|
|
|
May 15, 2023
Q1 2023
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-1.86M- 44.1% |
$10.3M - $15.3M
|
2.36M
$13.6M
|